In an effort to identify hemostatic components from Liparis nervosa (Thunb.) Lindl. using a bioactivity-guided fractionation approach, the n-BuOH extract was found to promote ADP-induced platelet aggregation and two compounds were isolated from the active extract. Compound 1 was a new nervogenic acid glycoside and the structure was elucidated as 3,5-bis(3-methyl-but-2-enyl)-4-O-[β-D-xylopyranosyl-(1→2)-β-D-glucopyranosyl]-benzoic acid by extensive spectroscopic measurements. Adenosine (2) was isolated from this plant for the first time. Compound 1 also showed good pro-coagulant activity in vitro.
Liparis nervosa (Thunb.) Lindl. (Orchidaceae) is a traditional medicinal plant widespread in China and has long been used for the treatment of internal and external bleeding, wound healing and ulcers, and snake bites [1] . A previous investigation of this plant led to the isolation of a new alkaloid named nervosine [2a] . In our research, the hemostatic activity of the light petroleum, diethylether, EtOAc and n-BuOH fractions of L. nervosa were investigated using a platelet aggregation test. The n-BuOH fraction possessed the best activity for promoting ADP-induced platelet aggregation, and its maximum aggregation rate was 56.5%, which was similar to the positive control (Yunnan Baiyao, 57.4%). A new nervogenic acid glycoside and a known compound, adenosine, were isolated.
Compound 1, C 28 H 40 O 12 [HRESIMS: m/z 591.2398 [M+Na] + (calcd. for C 28 H 40 NaO 12 591.2412] exhibited UV absorptions at 230, 248 and 290 nm, suggesting a benzoic acid nature. The IR spectrum showed absorption bands for hydroxyl (3400 cm -1 ) and carbonyl (1720-1689 cm -1 ) groups. The 1 H NMR spectrum displayed a singlet at δ 7.68 (2H), supporting the presence of an aromatic ring. The triplet at δ 5.33 (t, 2H, J = 7.2 Hz), the doublet at δ 3.57 (d, 4H, J =7.2 Hz), as well as the two singlets at δ1.78 (6H) and 1.76 (6H) suggested two symmetric isoprenyl groups. HMBC correlations of the proton at δ 7.68 (H-2 and H-6) with the carbon resonance at δ 170.4 (C-7) were observed, which indicated a carboxylic group connected to C-1. The location of the two isoprenyl groups was assigned at C-3 and C-5 according to the HMBC correlations of H-1′/1′′ (δ 3.57) with C-2, C-3, C-4, C-5, and C-6. Thus, the aglycone moiety was established as nervogenic acid (4-hydroxy-3,5-bis-(3-methyl-but-2-enyl)-benzoic acid) [2b,c] .
The observation of two anomeric protons at δ 4.74 and 4.79 and their corresponding carbons at δ 105.4 and 105.1 (Table 1) suggested the presence of two sugar units. Compound 1 was hydrolyzed to give D-glucose and D-xylose (GC analysis). The coupling constants of 7.8 and 6.6 Hz for the anomeric-H suggested β configurations. In the HMBC spectrum, the correlations between the anomeric proton of the glucose at δ 4.74 (1H, d, J =7.8 Hz) and assays. Compound 1 promoted the clot formation process of standardized human blood plasma in the PT test at 4 and 2 mg/mL, however, no activity could be observed at lower concentrations. In the case of the aPTT test, the activity was very weak according to the thromboplastin time.
Experimental
General: NMR, AV-600 Bruker; CC, silica gel; GC, Hewlett Packard 5890 Series II gas chromatograph.
Plant material: Whole plants of L. nervosa were collected from the hilly area of Sichuan province, China, in April 2010 and identified by Professor Fengzhen Chen, Chengdu University, where a voucher specimen (201004) has been deposited.
Extraction and isolation:
The powdered, dried, whole plants of L. nervosa (8 kg) were extracted with 85% EtOH, 2 times at 85 , and the crude extract (0.6 kg) was extracted in successive steps using light petroleum, diethylether, EtOAc and n-BuOH. The n-BuOH fraction (200 g) was subjected to a Macroporous Resin D101 column, eluted with a gradient of EtOH/H 2 O (0,30,60,90%) to give 4 fractions A, B, C, and D. Fraction C was subjected to CC on silica gel using CHCl 3 with increasing MeOH (0-100%). Fraction CIII was purified through silica gel CC to give 1 (50 mg) and 2 (20 mg).
Platelet aggregation assay:
The dried light petroleum, diethylether, EtOAc and n-BuOH fractions were dissolved in rapeseed oil /water (2:1). Wistar rats weighing 250-380 g were randomly distributed in 6 experimental groups (10 rats per group): (1) a control group received rapeseed oil/ water (2:1) (10 mL/kg), (2) a positive control group received Yunnan Baiyao powder (0.67 g/kg), (3-6) the light petroleum, diethylether, EtOAc and n-BuOH fractions (4 g/kg). Samples were administered once a day for 5 days. Two h after oral administration, rats were lightly anesthetized with diethylether. Blood was immediately taken from the abdominal aorta and anticoagulated with sodium citrate (3.5%), Platelet-rich plasma (PRP) was obtained from the supernatant fraction after centrifugation. The remaining blood was centrifuged and the supernatant gave the platelet-poor plasma (PPP). Aggregation tests were performed according to Born's turbidimetric method [2e].
Determination of the absolute configuration of sugars:
Compound 1 (5 mg) was hydrolyzed with 2 mol/L HCl (H 2 O-dioxane, 1:1; 4 mL) at 80 for 5 h. The reaction mixture was extracted with CHCl 3 (5 mL) and the aqueous layer was neutralized with Amberlite IRA67 (OHform), and concentrated to dryness. The residue was dissolved in pyridine (1 mL), to which a pyridine solution (1 mL) of L-cysteine methyl ester hydrochloride (2 mg) was added; the mixture was heated at 60 for 1 h. The solvent was evaporated under a N 2 stream and dried in vacuo. Then trimethylsilylimidazole (1 ml) was added, and the mixture heated at 60 for 0.5 h. After the addition of n-hexane and water (1 mL each), the n-hexane layer was analyzed by GC [2f,3]. The retention times of the peaks were 18.35 min (D-xylose) and 37.84 min (D-glucose), which were consistent with the reference compounds.
In vitro clotting assays: Clotting assays of activated partial thromboplastin time (aPTT) and prothrombin time (PT) were performed using standardized human plasma [4] . Compound 1 was dissolved in 60% ethanol solution. Yunnan Baiyao powder was also dissolved in 60% ethanol solution (2 mg/mL), which was filtered through a 0.22 µm filter.
Determination of aPTT:
The partial thromboplastin with activator -TriniCLOT aPTT HS was pre-warmed in a dry bath to 37°C. A solution of calcium chloride (0.025M) was also incubated under the same conditions. Then 100 µL of plasma solution was placed in a test tube with 20 µL of 60% ethanol solution, for the control test, and 20 µL of 60% ethanol solution of Yunnan Baiyao powder, for the positive control. After incubating for 3 min in the dry bath, 50 µL of the partial tromboplastin solution with activator was added, and the contents were mixed rapidly. The mixture was then incubated for another 3 min at 37 , and then 50 µL of the prewarmed calcium chloride solution was added while simultaneously starting a timer. The test tube was then gently tilted back and forth, until a clot formed, and the clotting time was recorded. For the tests, instead of 60% ethanol solution 20 µL of the prewarmed sample solution was mixed with 100 µL of plasma.
Determination of PT: Thromboplastincalcium reagent -
TriniCLOT PTHTF was reconstituted with distilled water. It was then incubated in a dry bath at 37 for at least 30 min before the test was commenced. Human plasma was also reconstituted with distilled water according to the manufacturer's instructions. 100 µL of plasma was placed in a test tube and 20 µL of 60% ethanol solution, for the control test, and 20 µL of a 60% ethanol solution of Yunnan Baiyao powder for the positive test. This mixture was incubated in the dry bath for 3 min. Thereafter, 100 µL of prewarmed thromboplastin-calcium reagent was rapidly added to the plasma while simultaneously starting a timer. The test tube was then gently tilted back and forth, until a clot formed, and the clotting time was recorded. For the tests, instead of 60% ethanol solution, 20 µL of the pre-warmed sample solution was mixed with 100 µL of plasma. All experiments were carried out in duplicate. 
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